STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Argan, Inc Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

James W. Quinn, Director of Argan (NYSE: AGX), received a new grant of 530 Time-Based Restricted Stock Units (TRSUs) on June 17, 2025. This equity compensation award represents part of the director's compensation package.

Key details of the transaction:

  • The TRSUs have a $0 exercise price
  • Full vesting is scheduled for April 17, 2026
  • Each TRSU converts to one share of common stock
  • Following this grant, Quinn beneficially owns 3,947 TRSUs directly

The filing was reported through Form 4 on June 20, 2025, within the required reporting window for insider transactions. Quinn serves as a non-employee director and is not a 10% owner of the company. The grant appears to be part of the company's standard director compensation program.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
QUINN JAMES W

(Last) (First) (Middle)
C/O ALLEN & COMPANY, 711 FIFTH AVENUE

(Street)
NEW YORK NY 10022

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ARGAN INC [ AGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/17/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Time-Based Restricted Stock Units $0 06/17/2025 A 530 (1) (1) Common Stock 530 $0 3,947 D
Explanation of Responses:
1. On June 17, 2025, the Reporting Person was granted Time-Based Restricted Stock Units ("TRSUs") covering 530 shares of the Issuer's common stock. The TRSUs will vest fully on April 17, 2026.
/s/ James W. Quinn 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What type of stock award did AGX director James Quinn receive on June 17, 2025?

James Quinn received 530 Time-Based Restricted Stock Units (TRSUs) of AGX common stock on June 17, 2025. These TRSUs were granted at a conversion price of $0 and will fully vest on April 17, 2026.

How many AGX restricted stock units does James Quinn own after the June 2025 grant?

Following the reported transaction, James Quinn beneficially owns 3,947 Time-Based Restricted Stock Units (TRSUs) of AGX stock, held in direct ownership form.

When will James Quinn's new AGX restricted stock units vest?

The 530 Time-Based Restricted Stock Units (TRSUs) granted to James Quinn on June 17, 2025, will vest fully on April 17, 2026.

What is James Quinn's role at AGX according to the Form 4?

According to the Form 4 filing, James Quinn serves as a Director of Argan Inc (AGX). This is indicated by the 'X' marked in the Director box under the relationship to issuer section.
Argan Inc

NYSE:AGX

AGX Rankings

AGX Latest News

AGX Latest SEC Filings

AGX Stock Data

4.63B
13.31M
4.48%
89.2%
5.37%
Engineering & Construction
Construction - Special Trade Contractors
Link
United States
ARLINGTON